NervGen Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -14 | -14 | 29 | -13 |
EBITDA | -12,505 | -1,689 | 6,732 | -4,147 |
EBIT | -12,519 | -1,703 | 6,706 | -4,161 |
Net Income | -29,991 | -1,703 | -31,702 | -4,161 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,806 | -8,336 | -10,127 | -5,325 |
Cash | 86,931 | 16,547 | 22,069 | 11,380 |
Basic Shares | 92,443 | 79,900 | 72,330 | 73,162 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -83 | -145 | -114 | |
EBITDA | -5,651 | -23,906 | -22,238 | -19,915 |
EBIT | -5,707 | -23,989 | -22,384 | -20,029 |
Net Income | -44,117 | -23,989 | -22,384 | -20,540 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,499 | -16,829 | -11,302 | -17,648 |
Cash | 22,069 | 17,255 | 11,660 | 22,254 |
Basic Shares | 72,330 | 67,321 | 59,290 | 52,649 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.37 |
2026-03-31 | -$0.06 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.04 |